SHAIRA COHEN: Open Payments
NPI 1487280574 · NORWALK, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,100 in 48 payments from 24 companies in 2025. Trend: 2023 $1,384 · 2024 $2,469 · 2025 $1,100
Food & beverage: $1,100
| Company | Payments | Amount |
|---|---|---|
| Rigel Pharmaceuticals, Inc. | 5 | $133 |
| Novartis Pharmaceuticals Corporation | 4 | $105 |
| AstraZeneca Pharmaceuticals LP | 4 | $99 |
| E.R. Squibb & Sons, L.L.C. | 3 | $76 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| ABBVIE INC. | 3 | $66 |
| Janssen Biotech, Inc. | 2 | $62 |
| Gilead Sciences, Inc. | 2 | $61 |
| Eisai Inc. | 2 | $47 |
| Celgene Corporation | 2 | $47 |
Products named: TAVALISSE, ENHERTU, Fabhalta, Trodelvy, OPDUALAG, BLENREP, Lenvima, REBLOZYL.
Industry payments across CT — which companies pay providers there.
